What this trial studies
This study will be conducted to determine the effect of circuit training on bone mineral density in post menopausal period.
Conditions in scope
- Post Menopausal
- Osteoporosis
Interventions
- Group A (control group): It will be consisted of twenty two post menopausal women who will receive daily dosage of vitamin D3 supplement (600 IU/day) (Schleicher et al., 2016), for 6 week (Other) — 1-Dumbbells (set B08Z7SY6SP ,Gymbit , made in China) :They will be used for the treatment procedures of circuit training for all postmenopausal women in group B. Its surface is coated with vinyl for scratch resistance and to provide them with…
- 1-Dumbbells (set B08Z7SY6SP ,Gymbit , made in China) :They will be used for the treatment procedures of circuit training for all postmenopausal women in group B. Its surface is coated with vinyl fo (Device) — 1-Dumbbells (set B08Z7SY6SP ,Gymbit , made in China) :They will be used for the treatment procedures of circuit training for all postmenopausal women in group B. Its surface is coated with vinyl for scratch resistance and to provide them with…
Who can join
Women only · Ages 50 Years to 60 Years · Accepts healthy volunteers.
Inclusion criteria
- Post menopausal women (at least 12 months after cessation of menstruation. Their ages will range from 50 -60 years old. Their body mass index (BMI) will be less than 30 Kg/m2. All of them have vitamin D potential deficiency (insufficiency) from 30nmol to 50nmol .
- Their T-score on DEXA will range from -1.1 to -2.4 indicates osteopenia or low bone density.
- They must be able to ambulate independently. All of them must be sedentary life style.
Exclusion criteria
- All women will be excluded if they have one of the following criteria:
- Thyroid, kidney and liver dysfunction. Cardiovascular diseases, severe anemia, uncontrolled diabetes mellitus. Any chest surgery, chronic obstructive pulmonary disease, malignancy. Renal failure, myocardial infarction, myasthenia gravis, hyperthyroidism. Hemorrhage, acute viral disease, acute tuberculosis, mental disorders, or those with pacemakers.
- Musculoskeletal disorders or women who received corticosteroids in the last 6 months prior to the study.
Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.
Where it’s happening
| City | State / Region | Facility | Site status |
|---|---|---|---|
| Cairo | Outpatient-clinic of Gynecology and Obstetrics in Mashtoul Elsouq Central Hospital, Egypt. | Recruiting |
Status & timeline
- Overall status: Recruiting
- Study type: Interventional
- Phase: N/A
- Start date: 2025-01-01
- Primary completion: 2025-06-01
- Last update posted: 2025-04-30
- First posted: 2025-04-30
Sponsor & contact
Lead sponsor: Cairo University (Other)
For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.
Outcome measures
Primary outcomes
- Bone mineral density (6 months)
A dual-energy x-ray absorptiometry (Hologic Delphi Dexa Scanner) (DEXA): It will be used to assess the bone mineral density for all women in both groups (A and B) before and after the end of the study program.
Related ClearedRx care
If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.
Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT06950463 before contacting a site.
ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.